FindTrial
Sign In

trial to compare the effects of 0.2% ropivacaine(local anaesthetic) administered as continuous infusion or programmed intermittent boluses in adductor canal block(pripheral nerve block) in patients undergoing unilateral total knee arthroplasty

To compare the effects of 0.2% Ropivacaine Continuous Infusion(CI) versus Programmed Intermittent Bolus(PIB) on post operative analgesia with adductor canal block in patients undergoing unilateral knee arthroplasty-A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024376
Enrollment
60
Registered
2020-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Programmed Intermittent Bolus(PIB): To compare the pain scores and effect of local anaesthetics in patients recieving continuous infusion versus programmed intermittent boluses in ultra

Sponsors

Christian Medical CollegeVellore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -All consenting patients - age above 18 years -asa 1 and2 -unilateral knee arthroplasty

Exclusion criteria

Exclusion criteria: refusal of anaesthesia -pregnancy -neurological or neuromuscular disease - history of chronic pain -allery to local anaesthetic

Design outcomes

Primary

MeasureTime frame
Post operative pain scores over first 72 hoursTimepoint: post operative pain scores over first 72 hours—

Secondary

MeasureTime frame
Amount of 0.2% ropivacaine used during the study periodTimepoint: 24h,48h,72h;Amount of adjunct pain medications usedTimepoint: 24h,48h,72h;Patient satisfactionTimepoint: 24,48,72h ;Plasma concentration of 0.2% ropivacaineTimepoint: 24h,48h,72h;Quadriceps motor strength by MRC and TUG testTimepoint: 24,48,72h;Side effects or complicationsTimepoint: 24h,48h,72h—

Countries

India

Contacts

Public ContactAnu Krupa Thomas

Christian Medical College,Vellore

serina.ruth@cmcvellore.ac.in9442307738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026